Korse CM - Search Results

1

Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer.

Muller M, Hoogendoorn R, Moritz RJG, van der Noort V, Lanfermeijer M, Korse CM, van den Broek D, Ten Hoeve JJ, Baas P, van Rossum HH, van den Heuvel MM. Muller M, et al. Among authors: korse cm. Tumour Biol. 2021;43(1):115-127. doi: 10.3233/TUB-211504. Tumour Biol. 2021. PMID: 34219680 Free article. Clinical Trial.

2

Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18.

Bonfrer JM, Groeneveld EM, Korse CM, van Dalen A, Oomen LC, Ivanyi D. Bonfrer JM, et al. Among authors: korse cm. Tumour Biol. 1994;15(4):210-22. doi: 10.1159/000217894. Tumour Biol. 1994. PMID: 7524130

3

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Gallee MP, Hart AA, Müller M, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Among authors: korse cm. Cancer. 1994 Oct 15;74(8):2307-13. doi: 10.1002/1097-0142(19941015)74:8<2307::aid-cncr2820740815>3.0.co;2-x. Cancer. 1994. PMID: 7922982

4

Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.

Bonfrer JM, Linders TC, Hageman PC, Hilkens JG, Korse CM, Molthoff CF. Bonfrer JM, et al. Among authors: korse cm. Tumour Biol. 1997;18(4):232-40. doi: 10.1159/000218036. Tumour Biol. 1997. PMID: 9218008

5

Cyfra 21-1 and TPA as markers in malignant mesothelioma.

Bonfrer JM, Schouwink JH, Korse CM, Baas P. Bonfrer JM, et al. Among authors: korse cm. Anticancer Res. 1997 Jul-Aug;17(4B):2971-3. Anticancer Res. 1997. PMID: 9329578

6

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.

Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P. Schouwink H, et al. Among authors: korse cm. Lung Cancer. 1999 Jul;25(1):25-32. doi: 10.1016/s0169-5002(99)00044-6. Lung Cancer. 1999. PMID: 10466859

7

Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.

Kok M, Bonfrer JM, Korse CM, de Jong D, Kersten MJ. Kok M, et al. Among authors: korse cm. Tumour Biol. 2003 Jan-Feb;24(1):53-60. doi: 10.1159/000070661. Tumour Biol. 2003. PMID: 12743427

8

Non-invasive diagnosis of pleural malignancies: the role of tumour markers.

van den Heuvel MM, Korse CM, Bonfrer JM, Baas P. van den Heuvel MM, et al. Among authors: korse cm. Lung Cancer. 2008 Mar;59(3):350-4. doi: 10.1016/j.lungcan.2007.08.030. Epub 2007 Oct 22. Lung Cancer. 2008. PMID: 17933420

9

Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer.

Vollebergh MA, Kappers I, Klomp HM, Buning-Kager JC, Korse CM, Hauptmann M, de Visser KE, van den Heuvel MM, Linn SC. Vollebergh MA, et al. Among authors: korse cm. J Thorac Oncol. 2010 Dec;5(12):1939-48. doi: 10.1097/JTO.0b013e3181f77a39. J Thorac Oncol. 2010. PMID: 21102259 Free article.

10

Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.

Korse CM, Bonfrer JM, Prevoo W, Baas P, Taal BG. Korse CM, et al. Tumour Biol. 2011 Aug;32(4):647-52. doi: 10.1007/s13277-011-0164-7. Epub 2011 Mar 5. Tumour Biol. 2011. PMID: 21373992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters